FDA Approves New Treatment for Metastatic Pancreatic Cancer
October 23rd 2015The FDA has approved the combination of irinotecan liposome injection plus 5-fluorouracil and leucovorin for the treatment of metastatic pancreatic cancer in patients who previously progressed on gemcitabine-based chemotherapy.